CTAD as a universal anticoagulant

The feasibility of CTAD (a mixture of citrate, theophylline, adenosine and dipyridamole) as a new anticoagulant for medical laboratory use was studied prospectively. Whole blood anticoagulated with CTAD exhibited results very similar to those of blood anticoagulated with EDTA on complete blood count...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokota, M., Tatsumi, N., Tsuda, I., Nishioka, T., Takubo, T.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2548379/
https://www.ncbi.nlm.nih.gov/pubmed/18924886
http://dx.doi.org/10.1155/S1463924603000038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2548379/
https://www.ncbi.nlm.nih.gov/pubmed/18924886
http://dx.doi.org/10.1155/S1463924603000038

Ejemplares similares